4.1: Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Emphysema: Emphysema damages air sacs in the lungs, called alveoli, reducing their elasticity and causing air to become trapped in the lungs.

Chronic Bronchitis: Chronic bronchitis is distinguished by persistent coughing and mucus secretion due to inflammation of the bronchial tubes and airways within the lungs.

Risk Factors for COPD:

• Cigarette Smoking: The primary risk factor for COPD, as it damages the lungs and airways.

• Environmental Exposures include secondhand smoke and occupational exposure to dust, chemicals, and other irritants.

• Air Pollution: COPD can be caused by both indoor and outdoor air pollution.

• Genetic Factors: Genetic abnormalities like alpha-1 antitrypsin deficiency can raise the risk of developing COPD.

• Age: The risk of COPD increases with age due to the cumulative effects of lung irritants and the natural aging of lung tissue.

• Respiratory Infections: Frequent respiratory infections during childhood and adulthood can contribute to the development of COPD.

• Socioeconomic Status: Lower socioeconomic status is often associated with higher exposure to risk factors for COPD.

Categories of COPD: COPD is typically categorized based on the severity of airflow limitation. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) offers a classification framework, based on forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC):

• FEV1 assesses the volume of air exhaled within one second during a forced breath.
• FVC is the total air exhaled during a forced breath.

Understanding these stages helps determine the appropriate treatment and management strategies for individuals with COPD. The stages are

• Mild COPD (GOLD 1): FEV1/FVC < 70% and FEV1 ≥ 80% predicted. Symptoms include minimal breathlessness, usually only during strenuous exercise, with chronic cough possibly being the only symptom.

• Moderate COPD (GOLD 2): FEV1/FVC < 70% and 50% ≤ FEV1 < 80% predicted. Increased breathlessness, especially during exertion, with chronic cough and frequent respiratory infections.

• Severe COPD (GOLD 3): FEV1/FVC < 70% and 30% ≤ FEV1 < 50% predicted. Further airflow limitations worsened with increased shortness of breath, reduced exercise capacity, and repeated exacerbations.

• Very Severe COPD (GOLD 4): FEV1/FVC < 70% and FEV1 < 30% predicted, or FEV1 < 50% predicted, plus chronic respiratory failure. Severe airflow limitations lead to life-threatening exacerbations and significant quality-of-life impairment.

Spirometry and imaging tests are the most commonly used diagnostic tools for COPD.

• Spirometry is the primary test used to diagnose COPD is measuring lung function.
• Imaging Tests, including Chest X-rays and CT scans, to visualize lung structure and any damage.

There are a variety of ways to manage and treat COPD.

• Smoking Cessation: The most vital step in managing COPD.

• Medications: Including bronchodilators and inhaled steroids to reduce inflammation and open airways.

• Pulmonary Rehabilitation: A program of exercise, education, and support.

• Oxygen Therapy: For patients with severe COPD and low blood oxygen levels.

• Surgical Options: In select cases, lung volume reduction surgery or lung transplantation may be considered.

In conclusion, early detection and comprehensive management are vital for improving the quality of life for individuals with COPD.